Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: October 31, 2024
Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 30, 2024
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer.
Journal: Future oncology (London, England)
Published: September 13, 2023
Assessment of Clinical Response Following Atezolizumab and Bevacizumab Treatment in Patients With Neuroendocrine Tumors: A Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: April 07, 2022
Cost-effectiveness of pembrolizumab for the first-line treatment of patients with unresectable or metastatic MSI-H/dMMR colorectal cancer in the United States.
Journal: Journal of medical economics
Published: February 21, 2022
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Journal: The Lancet. Oncology
Published: December 14, 2021
Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer.
Journal: Cancer discovery
Published: September 28, 2021
Last Updated: 09/26/2026